Neuroendocrine tumors (NETs) comprise a broad family of tumors that may or may not be
associated with symptoms attributable to hormonal hypersecretion. The NCCN Clinical …

Neuroendocrine tumours (NETs) represent a less frequent and heterogeneous group of
tumours, which has experienced, in recent years, a significant increase in effective …

Interest in research on neuroendocrine tumors (NETs) has grown in the past 10 years,
coinciding with improvements in our understanding of the molecular pathogenesis of NETs …

Gastroenteropancreatic endocrine tumors (GEP-NETs) are relatively uncommon; comprising
approximately 0.5% of all human cancers. Although they often exhibit relatively indolent …

Through insights into the molecular genetics of neuroendocrine tumors (NETs), the genes
predisposing to multiple endocrine neoplasia (MEN) syndromes were identified. In MEN1 …

Introduction Pancreatic neuroendocrine tumors (PNETs) in hereditary syndromes pose a
significant challenge to clinicians. The rarity of these syndromes and PNETs itself make it …

Neuroendocrine neoplasms (NENs) are a rare group of cancers with heterogeneous
behaviour and mostly of unknown aetiology. Excluding some infrequent hereditary cancer …

Neuroendocrine tumors (NETs) are a heterogenous group of tumors that originate from
neuroendocrine cells, mainly in the pancreas and the gastrointestinal and …

Gastroenteropancreatic neuroendocrine tumors (GEP NETs) are relatively rare neoplasias
arising from the embryonic neural crest, neuroectoderm and endoderm. GEP NETs occur …

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are usually sporadic; however,
familial (inherited) syndromes, such as the multiple endocrine neoplasia 1 (MEN-1) …